BMS-790052 dihydrochloride;Daclatasvir dihydrochloride;BMS790052 HCl
| Post Date: |
Jan 23,2013 |
| Expiry Date: |
Jan 23,2014 |
| Detailed Description: |
Cas No. :1009119-65-6
Quantity: 1Kilograms
BMS-790052 is a first-in-class, highly-selective oral HCV NS5A inhibitor. NS5A is an essential component for hepatitis C virus (HCV) replication complex. BMS-790052 has broad genotype coverage and exhibits picomolar in vitro potency against genotypes 1a (EC50 50pm) and 1b (EC50 9pm). BMS-790052 produces a robust decline in HCV RNA (-3.6 logs after 48 hours from a single 100 mg) dosefollowing a single dose in patients chronically infected with HCV genotype 1.
http://www.chemscene.com/BMS-790052-dihydrochloride.html |
| CAS Registry Number: |
|
| Synonyms: |
;N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acid dimethyl ester hydrochloride;Daclatasvir dihydrochloride;Daclatasvir.2HCL; |
| Molecular Structure: |
|
| Company: |
ChemScene, LLC
[ United States ]
|
| Contact: |
Dr. Gao |
| Tel: |
732-484-9848 |
| Fax: |
888-484-5008 |
| Email: |
information@chemscene.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
